Congress is back in session and patent reform is on the table. Again.

Lawmakers came close to passing legislation in 2014, but their efforts were abruptly stymied when trial lawyers and the biotech and pharmaceutical lobby succeeded in convincing the leadership to stop the bill from reaching the Senate floor.